Global mycoplasma testing market is poised to observe a healthy growth rate of 11% by 2027

Growing R&D activities and investments, funding from government initiatives, rapid expansion in the biotechnology and pharmaceutical sectors, rising concerns about cell culture contamination, development of advanced cell culture technologies, rising demand for timely and accurate testing, and an increase in respiratory tract infections are some of the key factors driving the mycoplasma testing.